• Sarepta Therapeutics average ebit margin for 2023 was -42.2%, a 24.24% decline from 2022.
• Sarepta Therapeutics average ebit margin for 2022 was -55.7%, a 37.42% decline from 2021.
• Sarepta Therapeutics average ebit margin for 2021 was -89.01%, a 35.14% decline from 2020.

Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues